HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eli Glatstein Selected Research

Dihematoporphyrin Ether (Porfimer Sodium)

1/2017A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
9/2007Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
9/2006Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
4/2006A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis.
5/2005Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy.
1/2005Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy.
10/2004Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
7/2004Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.
6/2004Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread.
12/2002Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eli Glatstein Research Topics

Disease

20Neoplasms (Cancer)
01/2017 - 07/2002
5Malignant Mesothelioma
01/2020 - 03/2003
5Fibrosarcoma
01/2017 - 12/2002
5Mesothelioma
05/2012 - 03/2003
5Carcinoma (Carcinomatosis)
02/2012 - 03/2004
4Sarcoma (Soft Tissue Sarcoma)
10/2020 - 03/2004
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2012 - 05/2002
3Prostatic Neoplasms (Prostate Cancer)
10/2013 - 01/2006
3Lymphoma (Lymphomas)
01/2012 - 03/2004
3Hypoxia (Hypoxemia)
05/2007 - 12/2002
2Neoplasm Metastasis (Metastasis)
10/2020 - 07/2016
2AIDS-Related Complex (ARC)
03/2017 - 07/2002
2Hodgkin Disease (Hodgkin's Disease)
01/2012 - 12/2008
2Peritoneal Neoplasms
04/2006 - 01/2005
2Ovarian Neoplasms (Ovarian Cancer)
10/2005 - 03/2004
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2014
1Breast Neoplasms (Breast Cancer)
02/2012
1Lung Neoplasms (Lung Cancer)
02/2012
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2008
1Colonic Neoplasms (Colon Cancer)
09/2006
1Pericardial Effusion
09/2005
1Radiodermatitis
09/2005
1Brain Neoplasms (Brain Tumor)
10/2004
1Alopecia (Baldness)
10/2004
1Hypoglycemia (Reactive Hypoglycemia)
10/2004
1Residual Neoplasm
03/2004
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2004
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2004
1Capillary Leak Syndrome
07/2003
1Wounds and Injuries (Trauma)
03/2003
1Burns
03/2003

Drug/Important Bio-Agent (IBA)

181-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2020 - 12/2002
10Dihematoporphyrin Ether (Porfimer Sodium)FDA Link
01/2017 - 12/2002
5Pharmaceutical PreparationsIBA
01/2017 - 07/2004
5Oxygen (Dioxygen)IBA
05/2007 - 12/2002
5Photosensitizing Agents (Photosensitizers)IBA
05/2007 - 06/2004
3Hemoglobins (Hemoglobin)IBA
09/2007 - 10/2004
2acetamideIBA
05/2007 - 07/2004
2motexafin lutetium (Lutrin)IBA
05/2007 - 01/2006
1Pemetrexed (MTA)FDA Link
03/2017
1Singlet OxygenIBA
01/2017
1Rituximab (Mabthera)FDA Link
02/2014
1Radium-223IBA
10/2013
1IsotopesIBA
07/2013
1Cetuximab (Erbitux)FDA Link
10/2005
1GemcitabineFDA Link
09/2005
1Dronabinol (THC)FDA LinkGeneric
01/2005
1carbogenIBA
10/2004
1Indicators and Reagents (Reagents)IBA
10/2004
1tempolIBA
10/2004
1nitroxylIBA
10/2004
1A-factor (Streptomyces)IBA
07/2004
1Immunoglobulin M (IgM)IBA
03/2004
1ParaproteinsIBA
03/2004
1Monoclonal AntibodiesIBA
03/2004
1IodineIBA
03/2004
1tositumomab I-131 (Bexxar)FDA Link
03/2004
1CytokinesIBA
07/2003
1temoporfinIBA
03/2003

Therapy/Procedure

20Photochemotherapy (Photodynamic Therapy)
01/2020 - 03/2003
9Radiotherapy
03/2017 - 07/2002
8Therapeutics
03/2017 - 07/2002
5Drug Therapy (Chemotherapy)
10/2020 - 03/2004
4Pneumonectomy (Lung Volume Reduction)
05/2012 - 03/2003
4Combined Modality Therapy
01/2012 - 05/2002
2Lasers (Laser)
01/2017 - 01/2006
2Radioimmunotherapy
06/2008 - 03/2004
2Aftercare (After-Treatment)
01/2006 - 10/2004
1Particle Accelerators
07/2016
1Mastectomy (Mammectomy)
02/2012
1Segmental Mastectomy (Lumpectomy)
02/2012
1Contraindications
09/2005
1Electrodes (Electrode)
12/2002